Good morning everyone, and welcome to October 25, 2024 – an important date in the history of being a truthful person.

That’s because it was on this day in 1932 that Benito Mussolini made a solemn declaration to the people of Italy, proclaiming that he would remain dictator for 30 years.

He only fell short on his promise by a scant 17 years, after Communist partisans shot him for being a prick in 1945.

 

Italian dictator Benito Mussolini, pictured here blasting a spritz of air freshener out of his hat to mask symptoms of being lactose intolerant. Pic: Getty Images.

Luckily, you won’t have to make all sorts of wild, unkeepable promises in order to get your hands on good pre-market info today.

That’s because – as always – we’ve worked super-hard to gather together lots of fiddly little things below, so you don’t need to go ferreting all over the internet for your ASX info this morning.

 

COMMODITY/FOREX/CRYPTO MARKET PRICES

Gold: US$2,725.72/oz (+0.28%)

Silver: US$33.88/oz (+0.39%)

Iron Ore: US$101.60/t (-0.20%)

Nickel (3mth): US$15,858/t (-2.74%)

Copper (3mth): US$9,363/t (-1.33%)

Zinc: US$3,165/t (+0.44%)

Oil (WTI): US$71.70/bbl (+0.94%)

Oil (Brent): US$75.83/bbl (+0.89%)

AUD/USD: 0.6647 (-0.12%)

Bitcoin: US$67,337.37 (+1.01%)

 

WHAT GOT YOU TALKING

What’s happening in Canada? Could it be that there’s something of a copper-based renaissance for the most northern part of the nice bit of North America? Jess Cummins investigates…

 

YESTERDAY’S ASX SMALL CAP LEADERS

Here are the best performing ASX small cap stocks:

Swipe or scroll to reveal full table. Click headings to sort:

Wordpress Table Plugin

 

Yesterday’s Small Cap Winners included:

Bowen Coking Coal (ASX:BCB) released its quarterly this morning, announcing that “robust mining performance” has delivered 769Kt ROM for the quarter, while the company has managed a mining cost reduction of 7% to $53/ROMt including boxcut costs and 52% lower than this time last year. That has led to 444Kt of saleable coal produced with sales of 415Kt recorded in the quarter, at an average coal price of A$216/t, down slightly on pcp.

Auking Mining (ASX:AKN) was rising today on news that the company has completed the purchase of the Grand Codroy uranium exploration project in Newfoundland,Canada. The project features uranium mineralisation within extensive, organic-rich siliciclastic rocks is similar to sandstone-hosted uranium districts in the western United States, and exploration work has returned high-grade historical rock samples including Sample 153: >20,000ppm (2%) Cu and 435ppm U, and Sample 3522: >20,000ppm (2%) Cu and 400ppm U.

Adelong Gold (ASX:ADG) was up on news that it has entered a binding farm-in agreement with Great Divide Mining (ASX:GDM) for a staged acquisition of up to 51% interest in the Adelong Gold Project. Under the agreement, GDM is set to invest $300,000 for an initial 15% stake in Challenger Gold Mines (following successful due diligence), and will earn a further 36% interest upon achieving first gold production from the refurbished Adelong Gold Plant within 12 months, bringing their total interest to 51%.

Earlier, Chimeric Therapeutics (ASX:CHM) was up on news that the company’s Phase 1B ADVENT-AML clinical trial has completed enrolment of relapsed or refractory Acute Myeloid Leukaemia subjects in the dose-finding portion of the clinical trial. The trial is an investigator-initiated study currently open to enrolment at The University of Texas MD Anderson Cancer Center under Principal Investigator Abhishek Maiti MD, Assistant Professor in the Department of Leukaemia.

Duketon Mining (ASX:DKM) was riding high on the release of its September quarterly report which goes into detail of early exploration activities currently underway at the Barlee gold and lithium project, 200km north of Southern Cross in WA. Various programs including desktop reviews, field reconnaissance, mapping and rock-chip sampling are on the go with a number of incoming proposals from external third parties being reviewed as well. Duketon’s tenement package lies along strike and adjacent to Regis Resources’ (ASX:RRL) landholding including the Rosemont, Garden Well and Moolart Well gold mines.

TMK Energy (ASX:TMK) reminded eligible shareholders that its Entitlement Issue closes tomorrow, 25 October, at 5.00pm AWST, with no extensions. Many shareholders, including the Board and Management, have shown strong support for the offer, taking up significant portions of their entitlements. Currently, the second pilot well (LF-06) is drilling at 226 metres in Mongolia, with further updates expected as drilling progresses. CEO Dougal Ferguson encourages all eligible shareholders to consider this opportunity to participate in the company’s success before the deadline.

Greenvale Energy (ASX:GRV) rose after announcing positive results from its Liquefaction Test Program 5, conducted by the University of Jordan for its Alpha Torbanite Project in Queensland. This program aimed to improve the viscosity of the bitumen product, with results suggesting that a premium-grade C170 product could be achieved with further adjustments.

The tests explored various conditions, including temperature and pressure, to maximise bitumen yield and quality. While viscosity measurements were limited due to small sample sizes, the findings indicate that optimising these conditions could lead to a product that meets the desired specifications. The Greenvale Board will now evaluate the results to decide on the next steps for the project.

Wellnex Life (ASX:WNX) said it was progressing with its dual listing on the London Stock Exchange (LSE) after announcing plans in April. The company successfully completed a placement with UK investors at $1.40 per share, showing strong support for its move. Wellnex expects to generate a significant portion of its revenue from the UK and Europe, particularly with its Haleon partnership. The company is finalising the necessary regulatory steps, including those related to its medicinal cannabis business, and aims to complete the listing by the end of 2024. An extraordinary general meeting held on 26 September approved the issuance of shares to support this process, which will enhance its international presence and investor reach.

And, Rhythm Biosciences (ASX:RHY) said it hopes to be able to get its blood-based bowel cancer screening test to market.

In a prezzo released this morning, Rhythm says it is in the “final stages of development” of the second-generation version of its lead assay, Colostat. Colostat shows great promise in replacing the maligned ‘poo test’, which is less accurate and not exactly user-friendly. The federal government’s national program provides free poo tests for those aged between 45 to 74. But the ‘ick’ factor means participation is low which is a pity because (a) it saves lives and (b) the program costs a sh*tload to run.

 

YESTERDAY’S ASX SMALL CAP LAGGARDS

Here are the worst performing ASX small cap stocks:

Swipe or scroll to reveal full table. Click headings to sort:

Wordpress Table Plugin

 

TRADING HALTS 

Brightstar Resources (ASX:BTR) – pending an announcement regarding a response to an ASX Price Query.

Great Divide Mining (ASX:GDM) – potential material transaction.

Orthocell (ASX:OCC) – pending an announcement in relation to a proposed capital raising.

Mithril Silver and Gold (ASX:MTH) – pending an announcement in relation to a proposed capital raising.

Lefroy Exploration (ASX:LEX)  – pending release of an announcement regarding a capital raising.

Nyrada (ASX:NYR) – pending an announcement regarding a proposed capital raising.

QX Resources (ASX:QXR) – pending an announcement in respect of a capital raising.

Sultan Resources (ASX:SLZ) – pending an announcement in relation to a capital raising.

Cosmo Metals (ASX:CMO) – pending an announcement regarding a capital raising.

Asian Battery Metals (ASX:AZ9) – following receipt of material assay results which requires time to compile and release to the market.

Eureka Group (ASX:EGH) – pending an announcement regarding a capital raising.

HMC Capital (ASX: HMC) – pending an announcement in connection with a proposed acquisition and an equity raising.

OncoSil Medical (ASX:OSL) – pending an announcement in relation to a capital raise.

 

At Stockhead, we tell it like it is. This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.